Non-communicable Diseases and COVID-19; a double-edged sword A Special Communication from IRAN-Reference-Cited by-同舟云学术

Non-communicable Diseases and COVID-19; a double-edged sword A Special Communication from IRAN

Published:2020-11-23 Issue:2 Volume:19 Page:2057-2061
ISSN:2251-6581
Container-title:Journal of Diabetes & Metabolic Disorders
language:en
Short-container-title:J Diabetes Metab Disord

Author:

Peykari Niloofar^ORCID,Eybpoosh Sana^ORCID,Safikhani Hamidreza,Haghdoost Ali Akbar^ORCID,Tabatabaei-Malazy Ozra^ORCID,Larijani Bagher^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://link.springer.com/content/pdf/10.1007/s40200-020-00683-1.pdf

Reference34 articles.

1. WHO. WHO Coronavirus Disease (COVID-19) Dashboard. https://covid19.who.int/. 2020.

2. National Committee on COVID-19 Epidemiology MoHaME. http://corona.behdasht.gov.ir/files/site1/files/IRAN_COVID19_Factsheet_N.45_-13June_En.pdf. 2020.

3. Hunter DJ, Reddy KS. Noncommunicable diseases. N Engl J Med. 2013;369(14):1336–43.

4. GBD compare. Avaialble at: https://vizhub.healthdata.org/gbd-compare/.

5. Baradaran A, Ebrahimzadeh MH, Baradaran A, Kachooei AR. Prevalence of comorbidities in COVID-19 patients: a systematic review and meta-analysis. Arch Bone Jt Surg. 2020;8:247–55.

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The multifaceted investigation of DHEAS level in COVID-19 disease: Insights into disease severity, gender, age, comorbidities, and implications for tailored management;2024-07-18

2. Trend and projection of non-communicable diseases risk factors in Iran from 2001 to 2030;Scientific Reports;2024-04-06

3. Seroprevalence of SARS-CoV-2 IgG and IgM in Diabetic and Oncology patients at Pietersburg Hospital, Limpopo, South Africa;Journal of Medical Microbiology and Infectious Diseases;2023-06-01

4. Severity Status of COVID-19 and Its Associated Factors at the Nyarugenge Treatment Center in Rwanda;Cureus;2023-02-28

5. A year of experience with COVID ‐19 in patients with cancer: A nationwide study;Cancer Reports;2022-11-27